OMEROS CORP Inventory
OMEROS CORP (OMER) had Inventory of $842.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2026-08-12
- 2026-06-30: Inventory, Net $842.00K.
- 2026-03-31: Inventory, Net $183.00K.
- 2025-12-31: Inventory, Net $0.00.
- 2021-09-30: Inventory, Net $712.00K.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $842.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $183.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-12 |
| 2021-09-30 | $712.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $978.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $1.19M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.35M 10-Q · filed 2021-11-09 |
| 2020-09-30 | $1.54M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.89M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.21M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.15M 10-K · filed 2021-03-01 |
| 2019-09-30 | $1.17M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.19M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $736.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $88.00K 10-K · filed 2020-03-02 |
| 2018-09-30 | $214.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $235.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $247.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $443.00K 10-K · filed 2019-03-01 |
| 2017-09-30 | $822.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $905.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $960.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.13M 10-K · filed 2018-03-01 |
| 2016-09-30 | $1.40M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.78M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.97M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $472.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | $445.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $633.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $566.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $568.00K 10-K · filed 2016-03-15 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |